The administration of IL-12/GM-CSF and Ig-4-1BB ligand markedly decreases murine floor of mouth squamous cell cancer

Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 3, 2008, Pages 442-448

  Adappa, Nithin D ^a   Sung, Chi Kwang ^a   Choi, Bryan ^a   Huang, Tian Gui ^a   Genden, Eric M ^a   Shin, Edward J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN 4 1BB; INTERLEUKIN 12; LIGAND; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUTH CARCINOMA; NONHUMAN; TUMOR VOLUME; VIRAL GENE THERAPY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY; INTERLEUKIN-12; MICE; MOUTH FLOOR; MOUTH NEOPLASMS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 49549104476     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2008.05.001     Document Type: Article

References (20)

1. Jacobs C., Lyman G., Velez-Garcia E., et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10 (1992) 257-263
2. Whiteside T.L. Immunobiology of head and neck cancer. Cancer Metastasis Rev 24 (2005) 95-105
3. Whiteside T.L. Tumor-induced death of immune cells: its mechanisms and consequences. Semin Cancer Biol 12 (2002) 43-50
4. Califano J., Van Der Reit P., Westra W., et al. A genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 (1996) 2488-2492
5. O'Malley Jr. B.W., Sewell D.A., Li D., et al. The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. Mol Endocrinol 11 (1997) 667-673
6. O'Malley Jr. B.W., Li D., Buckner A., et al. Limitation of adenovirus-mediated interleukin-2 gene therapy for oral cancer. Laryngoscope 109 (1999) 389-395
7. O'Malley Jr. B.W., Cope K.A., Chen S., et al. Combination gene therapy for oral cancer in a murine model. Cancer Res 56 (1996) 1737-1741
8. Pham-Nguyen K., Yang W., Saxena R., et al. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. Int J Cancer 81 (1999) 813-819
9. Xu D., Gu P., Li Q., et al. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation. Int J Cancer 109 (2004) 499-506
10. Xu D., Sauter B.V., Meseck M., et al. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma. Gene Ther 12 (2005) 1526-1533
11. Pan P., Gu P., Li Q., et al. Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation. J Immunol 172 (2004) 4779-4789
12. Chen L, Huang TG, Meseck ML, et al. Rejection of metastic 4T1 breast cancer by attenuating Treg cells in combination with immune stimulation. (in press).
13. Moretta A., Bottino C., Vitale D., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19 (2001) 197-223
14. Laneir L. On guard-activating NK cell receptors. Nat Immunol 2 (2001) 23-27
15. Windhagen A., Anderson D.E., Carrizosa A., et al. IL-12 induces human T cells secreting IL-10 with IFN-γ. J Immunol 157 (1996) 1127-1131
16. Sousa C.R., Hieny S., Scharton-Kersen T., et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 186 (1997) 1799-1802
17. Shin E.J., Wanna G.B., Choi B., et al. Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma. Laryngoscope 117 (2007) 210-214
18. O'Malley Jr. B.W., Chen S., Schwartz M.R., et al. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 55 (1995) 1080-1085
19. Hanada K., Tsunoda R., and Hamada H. GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity. J Leukoc Biol 181 (1996) 90
20. Pan P.Y., Zang Y., Weber K., et al. OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases. Mol Ther 6 (2002) 528-536